Publication | Closed Access

Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines

InflammationCytokineUp-regulated Treg CellsAutoimmune DiseaseImmune RegulationImmunologyAtorvastatin-modified Dendritic CellsTh2 CytokinesAutoimmunityImmunomodulationDendritic Cell BiologyImmunopathologyImmunotherapyMedicineCell Biology